Fremanezumab, Migraine and Sleep

Clinical trial NCT04693533 · TERMINATED

Trial details

NCT number: NCT04693533
Sponsor: Beth Israel Deaconess Medical Center
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Migraine Disorders Sleep Disorder

Start date: 2021-07-29
Primary completion: 2024-04-01
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.